Opaganib Promotes Weight Loss and Suppresses High-Fat Diet-Induced Obesity and Glucose Intolerance
Lynn W Maines, Staci N Keller, Ryan A Smith, Charles D Smith Apogee Biotechnology Corporation, Hummelstown, PA, USACorrespondence: Charles D Smith, Apogee Biotechnology Corporation, 1214 Research Blvd, Suite 2015, Hummelstown, PA, 17036, USA, Email cdsmith@apogee-biotech.comIntroduction: Sphingolipi...
Saved in:
| Main Authors: | Maines LW, Keller SN, Smith RA, Smith CD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-04-01
|
| Series: | Diabetes, Metabolic Syndrome and Obesity |
| Subjects: | |
| Online Access: | https://www.dovepress.com/opaganib-promotes-weight-loss-and-suppresses-high-fat-diet-induced-obe-peer-reviewed-fulltext-article-DMSO |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The association of dietary fat intake before and during pregnancy with the risk of gestational diabetes mellitus and impaired glucose intolerance: a systematic review and dose–response meta-analysis on observational investigations
by: Ghazaleh Bahrami, et al.
Published: (2025-07-01) -
Prognostic consequence of hyperglycemia points in oral glucose intolerance test for the course and outcomes of pregnancy in women with gestational diabetes mellitus
by: I. V. Bunak, et al.
Published: (2025-01-01) -
Glucose measurements in sheep using a long-term continuous glucose monitor designed for humans
by: Barbara Roqueto dos Reis, et al.
Published: (2024-11-01) -
Metabolites Link Intake of a Healthy Diet to Better Insulin and Glucose Homeostasis in the Microbiome and Insulin Longitudinal Evaluation Study (MILES)
by: Alexis C Wood, et al.
Published: (2024-11-01) -
Reference values of 24-hour, day-time and nocturnal glucose variability parameters in subjects with normal glucose tolerance
by: Ju. F. Semenova, et al.
Published: (2022-05-01)